The global Absorbable Coronary Artery Sirolimus-Eluting Stent System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Absorbable Coronary Artery Sirolimus-Eluting Stent System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Absorbable coronary artery sirolimus-eluting stent system is a medical device used to treat coronary artery stenosis. It combines a stent made of biodegradable materials with a drug coating containing sirolimus (also known as rapamycin). The system is designed to be implanted into the coronary artery through interventional surgery, providing support to the narrowed vessel, improving blood flow, and gradually degrading and being absorbed over time, avoiding the need for a permanent stent.

The North American market for Absorbable Coronary Artery Sirolimus-Eluting Stent System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Absorbable Coronary Artery Sirolimus-Eluting Stent System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Absorbable Coronary Artery Sirolimus-Eluting Stent System include Shanghai Micro-Invasive Medical Devices, Wanrui Feihong (Beijing), Shandong Huaan Biotechnology, Jiwei Medical, Lepu (Beijing) Medical, Baixinan Bio, Micell Technologies, QualiMed, Kossel, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Absorbable Coronary Artery Sirolimus-Eluting Stent System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Absorbable Coronary Artery Sirolimus-Eluting Stent System. The Absorbable Coronary Artery Sirolimus-Eluting Stent System market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Absorbable Coronary Artery Sirolimus-Eluting Stent System market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Absorbable Coronary Artery Sirolimus-Eluting Stent System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Report

Report Metric	Details
Report Name	Absorbable Coronary Artery Sirolimus-Eluting Stent System Market
Segment by Type	Single Coating Compound Coating
by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Shanghai Micro-Invasive Medical Devices, Wanrui Feihong (Beijing), Shandong Huaan Biotechnology, Jiwei Medical, Lepu (Beijing) Medical, Baixinan Bio, Micell Technologies, QualiMed, Kossel
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Absorbable Coronary Artery Sirolimus-Eluting Stent System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Absorbable Coronary Artery Sirolimus-Eluting Stent System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Absorbable Coronary Artery Sirolimus-Eluting Stent System Market report?

Ans: The main players in the Absorbable Coronary Artery Sirolimus-Eluting Stent System Market are Shanghai Micro-Invasive Medical Devices, Wanrui Feihong (Beijing), Shandong Huaan Biotechnology, Jiwei Medical, Lepu (Beijing) Medical, Baixinan Bio, Micell Technologies, QualiMed, Kossel

What are the Application segmentation covered in the Absorbable Coronary Artery Sirolimus-Eluting Stent System Market report?

Ans: The Applications covered in the Absorbable Coronary Artery Sirolimus-Eluting Stent System Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Absorbable Coronary Artery Sirolimus-Eluting Stent System Market report?

Ans: The Types covered in the Absorbable Coronary Artery Sirolimus-Eluting Stent System Market report are Single Coating, Compound Coating

1 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Overview

1.1 Product Definition

1.2 Absorbable Coronary Artery Sirolimus-Eluting Stent System by Type

1.2.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Value by Type: 2025 vs 2032

1.2.2 Single Coating

1.2.3 Compound Coating

1.3 Absorbable Coronary Artery Sirolimus-Eluting Stent System by Application

1.3.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Value by Application: 2025 vs 2032

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size Estimates and Forecasts

1.4.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue 2021–2032

1.4.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales 2021–2032

1.4.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Competition by Manufacturers

2.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Manufacturers (2021–2026)

2.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Absorbable Coronary Artery Sirolimus-Eluting Stent System, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Absorbable Coronary Artery Sirolimus-Eluting Stent System, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Absorbable Coronary Artery Sirolimus-Eluting Stent System, Product Types and Applications

2.7 Global Key Manufacturers of Absorbable Coronary Artery Sirolimus-Eluting Stent System, Date of Entry into the Industry

2.8 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Competitive Situation and Trends

2.8.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Players Market Share by Revenue

2.8.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Scenario by Region

3.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region: 2021–2032

3.2.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region: 2021–2026

3.2.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region: 2027–2032

3.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region: 2021–2032

3.3.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region: 2021–2026

3.3.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region: 2027–2032

3.4 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Facts & Figures by Country

3.4.1 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021–2032)

3.4.3 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Facts & Figures by Country

3.5.1 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021–2032)

3.5.3 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Facts & Figures by Region

3.6.1 Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region (2021–2032)

3.6.3 Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Facts & Figures by Country

3.7.1 Latin America Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021–2032)

3.7.3 Latin America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Facts & Figures by Country

3.8.1 Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021–2032)

3.8.3 Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Type (2021–2032)

4.1.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Type (2021–2026)

4.1.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Type (2027–2032)

4.1.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Type (2021–2032)

4.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Type (2021–2032)

4.2.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Type (2021–2026)

4.2.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Type (2027–2032)

4.2.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Type (2021–2032)

4.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Price by Type (2021–2032)

5 Segment by Application

5.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Application (2021–2032)

5.1.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Application (2021–2026)

5.1.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Application (2027–2032)

5.1.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Application (2021–2032)

5.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Application (2021–2032)

5.2.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Application (2021–2026)

5.2.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Application (2027–2032)

5.2.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Application (2021–2032)

5.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Shanghai Micro-Invasive Medical Devices

6.1.1 Shanghai Micro-Invasive Medical Devices Company Information

6.1.2 Shanghai Micro-Invasive Medical Devices Description and Business Overview

6.1.3 Shanghai Micro-Invasive Medical Devices Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Shanghai Micro-Invasive Medical Devices Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio

6.1.5 Shanghai Micro-Invasive Medical Devices Recent Developments/Updates

6.2 Wanrui Feihong (Beijing)

6.2.1 Wanrui Feihong (Beijing) Company Information

6.2.2 Wanrui Feihong (Beijing) Description and Business Overview

6.2.3 Wanrui Feihong (Beijing) Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Wanrui Feihong (Beijing) Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio

6.2.5 Wanrui Feihong (Beijing) Recent Developments/Updates

6.3 Shandong Huaan Biotechnology

6.3.1 Shandong Huaan Biotechnology Company Information

6.3.2 Shandong Huaan Biotechnology Description and Business Overview

6.3.3 Shandong Huaan Biotechnology Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Shandong Huaan Biotechnology Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio

6.3.5 Shandong Huaan Biotechnology Recent Developments/Updates

6.4 Jiwei Medical

6.4.1 Jiwei Medical Company Information

6.4.2 Jiwei Medical Description and Business Overview

6.4.3 Jiwei Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Jiwei Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio

6.4.5 Jiwei Medical Recent Developments/Updates

6.5 Lepu (Beijing) Medical

6.5.1 Lepu (Beijing) Medical Company Information

6.5.2 Lepu (Beijing) Medical Description and Business Overview

6.5.3 Lepu (Beijing) Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Lepu (Beijing) Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio

6.5.5 Lepu (Beijing) Medical Recent Developments/Updates

6.6 Baixinan Bio

6.6.1 Baixinan Bio Company Information

6.6.2 Baixinan Bio Description and Business Overview

6.6.3 Baixinan Bio Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Baixinan Bio Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio

6.6.5 Baixinan Bio Recent Developments/Updates

6.7 Micell Technologies

6.7.1 Micell Technologies Company Information

6.7.2 Micell Technologies Description and Business Overview

6.7.3 Micell Technologies Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Micell Technologies Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio

6.7.5 Micell Technologies Recent Developments/Updates

6.8 QualiMed

6.8.1 QualiMed Company Information

6.8.2 QualiMed Description and Business Overview

6.8.3 QualiMed Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 QualiMed Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio

6.8.5 QualiMed Recent Developments/Updates

6.9 Kossel

6.9.1 Kossel Company Information

6.9.2 Kossel Description and Business Overview

6.9.3 Kossel Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Kossel Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio

6.9.5 Kossel Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Chain Analysis

7.2 Absorbable Coronary Artery Sirolimus-Eluting Stent System Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Absorbable Coronary Artery Sirolimus-Eluting Stent System Production Mode & Process Analysis

7.4 Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Marketing

7.4.1 Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Channels

7.4.2 Absorbable Coronary Artery Sirolimus-Eluting Stent System Distributors

7.5 Absorbable Coronary Artery Sirolimus-Eluting Stent System Customer Analysis

8 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Dynamics

8.1 Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Trends

8.2 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Drivers

8.3 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Challenges

8.4 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Shandong Huaan Biotechnology

Jiwei Medical

Lepu (Beijing) Medical

Micell Technologies

QualiMed

Kossel

Shanghai Micro-Invasive Medical Devices

Wanrui Feihong (Beijing)

Baixinan Bio

List of Tables

Table 1. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Competitive Situation by Manufacturers in 2025

Table 4. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Absorbable Coronary Artery Sirolimus-Eluting Stent System Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Absorbable Coronary Artery Sirolimus-Eluting Stent System, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Absorbable Coronary Artery Sirolimus-Eluting Stent System, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Absorbable Coronary Artery Sirolimus-Eluting Stent System, Product Types and Applications

Table 12. Global Key Manufacturers of Absorbable Coronary Artery Sirolimus-Eluting Stent System, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Companies by Tier (Tier 1, Tier 2, Tier 3), based on Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region (K Units), 2021–2026

Table 18. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Region (2021–2026)

Table 19. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region (K Units), 2027–2032

Table 20. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Region (2027–2032)

Table 21. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region (US$ Million), 2021–2026

Table 22. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Region (2021–2026)

Table 23. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region (US$ Million), 2027–2032

Table 24. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Region (2027–2032)

Table 25. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (K Units), 2021–2026

Table 27. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (K Units), 2027–2032

Table 28. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (US$ Million), 2021–2026

Table 29. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (K Units), 2021–2026

Table 32. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (K Units), 2027–2032

Table 33. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (K Units), 2021–2026

Table 42. Latin America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (K Units), 2027–2032

Table 43. Latin America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Country (US$ Million), 2027–2032

Table 50. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units) by Type (2021–2026)

Table 51. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units) by Type (2027–2032)

Table 52. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Type (2021–2026)

Table 53. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Type (2027–2032)

Table 54. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Type (2021–2026)

Table 57. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Type (2027–2032)

Table 58. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Price (US$/Unit) by Type (2021–2026)

Table 59. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Price (US$/Unit) by Type (2027–2032)

Table 60. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units) by Application (2021–2026)

Table 61. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units) by Application (2027–2032)

Table 62. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Application (2021–2026)

Table 63. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Application (2027–2032)

Table 64. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Application (2021–2026)

Table 67. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Application (2027–2032)

Table 68. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Price (US$/Unit) by Application (2021–2026)

Table 69. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Price (US$/Unit) by Application (2027–2032)

Table 70. Shanghai Micro-Invasive Medical Devices Company Information

Table 71. Shanghai Micro-Invasive Medical Devices Description and Business Overview

Table 72. Shanghai Micro-Invasive Medical Devices Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Shanghai Micro-Invasive Medical Devices Absorbable Coronary Artery Sirolimus-Eluting Stent System Product

Table 74. Shanghai Micro-Invasive Medical Devices Recent Developments/Updates

Table 75. Wanrui Feihong (Beijing) Company Information

Table 76. Wanrui Feihong (Beijing) Description and Business Overview

Table 77. Wanrui Feihong (Beijing) Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Wanrui Feihong (Beijing) Absorbable Coronary Artery Sirolimus-Eluting Stent System Product

Table 79. Wanrui Feihong (Beijing) Recent Developments/Updates

Table 80. Shandong Huaan Biotechnology Company Information

Table 81. Shandong Huaan Biotechnology Description and Business Overview

Table 82. Shandong Huaan Biotechnology Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Shandong Huaan Biotechnology Absorbable Coronary Artery Sirolimus-Eluting Stent System Product

Table 84. Shandong Huaan Biotechnology Recent Developments/Updates

Table 85. Jiwei Medical Company Information

Table 86. Jiwei Medical Description and Business Overview

Table 87. Jiwei Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Jiwei Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Product

Table 89. Jiwei Medical Recent Developments/Updates

Table 90. Lepu (Beijing) Medical Company Information

Table 91. Lepu (Beijing) Medical Description and Business Overview

Table 92. Lepu (Beijing) Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. Lepu (Beijing) Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Product

Table 94. Lepu (Beijing) Medical Recent Developments/Updates

Table 95. Baixinan Bio Company Information

Table 96. Baixinan Bio Description and Business Overview

Table 97. Baixinan Bio Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. Baixinan Bio Absorbable Coronary Artery Sirolimus-Eluting Stent System Product

Table 99. Baixinan Bio Recent Developments/Updates

Table 100. Micell Technologies Company Information

Table 101. Micell Technologies Description and Business Overview

Table 102. Micell Technologies Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. Micell Technologies Absorbable Coronary Artery Sirolimus-Eluting Stent System Product

Table 104. Micell Technologies Recent Developments/Updates

Table 105. QualiMed Company Information

Table 106. QualiMed Description and Business Overview

Table 107. QualiMed Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. QualiMed Absorbable Coronary Artery Sirolimus-Eluting Stent System Product

Table 109. QualiMed Recent Developments/Updates

Table 110. Kossel Company Information

Table 111. Kossel Description and Business Overview

Table 112. Kossel Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 113. Kossel Absorbable Coronary Artery Sirolimus-Eluting Stent System Product

Table 114. Kossel Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Absorbable Coronary Artery Sirolimus-Eluting Stent System Distributors List

Table 118. Absorbable Coronary Artery Sirolimus-Eluting Stent System Customers List

Table 119. Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Trends

Table 120. Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Drivers

Table 121. Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Challenges

Table 122. Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Absorbable Coronary Artery Sirolimus-Eluting Stent System

Figure 2. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share by Type: 2025 & 2032

Figure 4. Single Coating Product Picture

Figure 5. Compound Coating Product Picture

Figure 6. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share by Application: 2025 & 2032

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size (US$ Million), 2021–2032

Figure 13. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), 2021–2032

Figure 14. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Average Price (US$/Unit), 2021–2032

Figure 15. Absorbable Coronary Artery Sirolimus-Eluting Stent System Report Years Considered

Figure 16. Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Share by Manufacturers in 2025

Figure 17. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Share by Manufacturers in 2025

Figure 18. Top 5 and Top 10 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Players: Market Share by Revenue in Absorbable Coronary Artery Sirolimus-Eluting Stent System in 2025

Figure 19. Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 21. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Country (2021–2032)

Figure 22. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Country (2021–2032)

Figure 23. United States Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Canada Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Country (2021–2032)

Figure 26. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Country (2021–2032)

Figure 27. Germany Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. France Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. U.K. Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Italy Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Russia Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Region (2021–2032)

Figure 33. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Region (2021–2032)

Figure 34. China Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Japan Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. South Korea Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. India Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Australia Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. China Taiwan Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Southeast Asia Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Latin America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Country (2021–2032)

Figure 42. Latin America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Country (2021–2032)

Figure 43. Mexico Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Brazil Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Argentina Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Colombia Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Country (2021–2032)

Figure 48. Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Country (2021–2032)

Figure 49. Turkey Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Saudi Arabia Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. UAE Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Global Sales Market Share of Absorbable Coronary Artery Sirolimus-Eluting Stent System by Type (2021–2032)

Figure 53. Global Revenue Market Share of Absorbable Coronary Artery Sirolimus-Eluting Stent System by Type (2021–2032)

Figure 54. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Price (US$/Unit) by Type (2021–2032)

Figure 55. Global Sales Market Share of Absorbable Coronary Artery Sirolimus-Eluting Stent System by Application (2021–2032)

Figure 56. Global Revenue Market Share of Absorbable Coronary Artery Sirolimus-Eluting Stent System by Application (2021–2032)

Figure 57. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Price (US$/Unit) by Application (2021–2032)

Figure 58. Absorbable Coronary Artery Sirolimus-Eluting Stent System Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions